Clinical Trial Update: The AutoloGel™ Post-Market Surveillance (TAPS) Program [NA]

View source ↗

Summary

The AutoloGel post-market surveillance trial (TAPS) was terminated; the program monitored safety and performance for wound-related indications, with no addition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers
• Leg Ulcers
• Pressure Ulcers

Drugs mentioned

• AutoloGel (autologous platelet-rich plasma gel)

Snippet

Sponsor: Cytomedix | Conditions: Wounds, Leg Ulcers | NA | Status: TERMINATED